Insiders Teva Pharmaceutical Industries Limited London S.E.

Equities

0LER

US8816242098

Market Closed - London S.E. Other stock markets 16:30:00 17/06/2024 BST			5-day change	1st Jan Change
16.95 ^USD	-3.14%		+1.44%	+62.43%

06-14	Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...
06-14	Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	05-17	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing	05-15	MT
Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024	05-15	CI
Teva Pharmaceutical Industries Insider Sold Shares Worth $657,240, According to a Recent SEC Filing	03-07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,048,119, According to a Recent SEC Filing	03-07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,352,090, According to a Recent SEC Filing	03-07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing	03-05	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,277,207, According to a Recent SEC Filing	03-05	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $270,176, According to a Recent SEC Filing	03-01	MT
Teva Pharmaceutical Industries Ltd. Appoints R. Ananthanarayanan as CEO of Its Teva Active Pharmaceutical Ingredients Business	11-07	CI
Teva Announces Changes to Executive Management Team	28/09/23	CI
Insider Sell: Teva Pharmaceutical Industries	09/08/23	MT
Insider Sell: Teva Pharmaceutical Industries	03/08/23	MT
Teva Pharmaceutical Industries Limited Appoints Varda Shalev as Member of the Board, Effective September 1, 2023	02/08/23	CI
INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised	02/08/23	MT
Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development, Effective August 1, 2023	27/07/23	CI
Jean-Michel Halfon to Resign from Board of Directors of Teva Pharmaceutical Industries Limited	11/05/23	CI
Insider Sell: Teva Pharmaceutical Industries	08/03/23	MT
Insider Sell: Teva Pharmaceutical Industries	08/03/23	MT
Insider Sell: Teva Pharmaceutical Industries	08/03/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 09:41 am

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 02, 2023 at 08:19 pm